472 related articles for article (PubMed ID: 36309048)
1. Gut microbiota and myocardial fibrosis.
Xu H; Yang F; Bao Z
Eur J Pharmacol; 2023 Feb; 940():175355. PubMed ID: 36309048
[TBL] [Abstract][Full Text] [Related]
2. Modulating the Microbiota as a Therapeutic Intervention for Type 2 Diabetes.
Huda MN; Kim M; Bennett BJ
Front Endocrinol (Lausanne); 2021; 12():632335. PubMed ID: 33897618
[TBL] [Abstract][Full Text] [Related]
3. Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: A comprehensive review.
Dai Y; Shen Z; Khachatryan LG; Vadiyan DE; Karampoor S; Mirzaei R
Pathol Res Pract; 2023 Sep; 249():154740. PubMed ID: 37567034
[TBL] [Abstract][Full Text] [Related]
4. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.
Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS
Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376
[TBL] [Abstract][Full Text] [Related]
5. Novel insights in the relationship of gut microbiota and coronary artery diseases.
Ramírez-Macías I; Orenes-Piñero E; Camelo-Castillo A; Rivera-Caravaca JM; López-García C; Marín F
Crit Rev Food Sci Nutr; 2022; 62(14):3738-3750. PubMed ID: 33399007
[TBL] [Abstract][Full Text] [Related]
6. Clostridium butyricum and Bifidobacterium pseudolongum Attenuate the Development of Cardiac Fibrosis in Mice.
Wang J; Chen J; Li L; Zhang H; Pang D; Ouyang H; Jin X; Tang X
Microbiol Spectr; 2022 Dec; 10(6):e0252422. PubMed ID: 36318049
[TBL] [Abstract][Full Text] [Related]
7. Anorexia nervosa and gut microbiome: implications for weight change and novel treatments.
Wei Y; Peng S; Lian C; Kang Q; Chen J
Expert Rev Gastroenterol Hepatol; 2022 Apr; 16(4):321-332. PubMed ID: 35303781
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk between Gut and Brain in Alzheimer's Disease: The Role of Gut Microbiota Modulation Strategies.
Shabbir U; Arshad MS; Sameen A; Oh DH
Nutrients; 2021 Feb; 13(2):. PubMed ID: 33669988
[TBL] [Abstract][Full Text] [Related]
9. Microbiota dysbiosis and myasthenia gravis: Do all roads lead to Rome?
Kapoor B; Gulati M; Gupta R; Singla RK
Autoimmun Rev; 2023 May; 22(5):103313. PubMed ID: 36918089
[TBL] [Abstract][Full Text] [Related]
10. Bacterial Metabolites: A Link between Gut Microbiota and Dermatological Diseases.
Stec A; Sikora M; Maciejewska M; Paralusz-Stec K; Michalska M; Sikorska E; Rudnicka L
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834904
[TBL] [Abstract][Full Text] [Related]
11. Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus.
Wu J; Yang K; Fan H; Wei M; Xiong Q
Front Endocrinol (Lausanne); 2023; 14():1114424. PubMed ID: 37229456
[TBL] [Abstract][Full Text] [Related]
12. Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases.
Ashique S; De Rubis G; Sirohi E; Mishra N; Rihan M; Garg A; Reyes RJ; Manandhar B; Bhatt S; Jha NK; Singh TG; Gupta G; Singh SK; Chellappan DK; Paudel KR; Hansbro PM; Oliver BG; Dua K
Chem Biol Interact; 2022 Dec; 368():110231. PubMed ID: 36288778
[TBL] [Abstract][Full Text] [Related]
13. Role of the intestinal microbiome and its therapeutic intervention in cardiovascular disorder.
Luqman A; Hassan A; Ullah M; Naseem S; Ullah M; Zhang L; Din AU; Ullah K; Ahmad W; Wang G
Front Immunol; 2024; 15():1321395. PubMed ID: 38343539
[TBL] [Abstract][Full Text] [Related]
14. Impact of gut microbiota: How it could play roles beyond the digestive system on development of cardiovascular and renal diseases.
Suganya K; Son T; Kim KW; Koo BS
Microb Pathog; 2021 Mar; 152():104583. PubMed ID: 33164814
[TBL] [Abstract][Full Text] [Related]
15. Influence of gut microbiota on eye diseases: an overview.
Napolitano P; Filippelli M; Davinelli S; Bartollino S; dell'Omo R; Costagliola C
Ann Med; 2021 Dec; 53(1):750-761. PubMed ID: 34042554
[TBL] [Abstract][Full Text] [Related]
16. Human gut microbiota/microbiome in health and diseases: a review.
Gomaa EZ
Antonie Van Leeuwenhoek; 2020 Dec; 113(12):2019-2040. PubMed ID: 33136284
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota and host metabolism in liver cirrhosis.
Usami M; Miyoshi M; Yamashita H
World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
[TBL] [Abstract][Full Text] [Related]
18. Interaction between gut microbiome and cardiovascular disease.
Peng J; Xiao X; Hu M; Zhang X
Life Sci; 2018 Dec; 214():153-157. PubMed ID: 30385177
[TBL] [Abstract][Full Text] [Related]
19. Restoration of dysbiotic human gut microbiome for homeostasis.
Dixit K; Chaudhari D; Dhotre D; Shouche Y; Saroj S
Life Sci; 2021 Aug; 278():119622. PubMed ID: 34015282
[TBL] [Abstract][Full Text] [Related]
20. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
Sun MF; Shen YQ
Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]